|
1
|
Peterson LS, Nelson AM and Su WP:
Classification of morphea (localized scleroderma). Mayo Clin Proc.
70:1068–1076. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zulian F and Martini G: Preliminary
classification criteria for juvenile systemic sclerosis. Zulian F
and Ruperto N: Proceedings of the II Workshop on nomenclature and
diagnostic criteria for Juvenile Scleroderma Syndromes (Padua).
5–16. 2005.
|
|
3
|
Newman MG, Takei H, Klokkevoid PR and
Carranza FA: Carranzas Clinical Periodontology (11th).
Philadelphia, PA: Elsevier Saunders. 3472012.
|
|
4
|
Browning JC: Pediatric morphea. Dermatol
Clin. 31:229–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murray KJ and Laxer RM: Scleroderma in
children and adolescents. Rheum Dis Clin North Am. 28:603–624.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uziel Y, Krafchik BR, Silverman ED,
Thorner PS and Laxer RM: Localized scleroderma in childhood: A
report of 30 cases. Semin Arthritis Rheum. 23:328–340. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laxer RM and Zulian F: Localized
scleroderma. Curr Opin Rheumatol. 18:606–613. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cantisani C, Miraglia E, Richetta AG,
Mattozzi C and Calvieri S: Generalized morphea successfully treated
with tacrolimus 0.1% ointment. J Drugs Dermatol. 12:14–15.
2013.PubMed/NCBI
|
|
9
|
Kroft EB, Groeneveld TJ, Seyger MM and de
Jong EM: Efficacy of topical tacrolimus 0.1% in active plaque
morphea: randomized, double-blind, emollient-controlled pilot
study. Am J Clin Dermatol. 10:181–187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zulian F, Vallongo C, Patrizi A,
Belloni-Fortina A, Cutrone M, Alessio M, Martino S, Gerloni V,
Vittadello F and Martini G: A long-term follow-up study of
methotrexate in juvenile localized scleroderma (morphea). J Am Acad
Dermatol. 67:1151–1156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Inamo Y and Ochiai T: Successful
combination treatment of a patient with progressive juvenile
localized scleroderma (morphea) using imatinib, corticosteroids,
and methotrexate. Pediatr Dermatol. 30:e191–e193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gambichler T, Terras S and Kreuter A:
Treatment regimens, protocols, dosage and indications for UVA1
phototherapy: Facts and controversies. Clin Dermatol. 31:438–454.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jia XY, Chang Y, Sun XJ, Wu HX, Wang C, Xu
HM, Zhang L, Zhang LL, Zheng YQ, Song LH and Wei W: Total
glucosides of paeony inhibit the proliferation of fibroblast-like
synoviocytes through the regulation of G proteins in rats with
collagen-induced arthritis. Int Immunopharmacol. 18:1–6. 2014.
View Article : Google Scholar : PubMed/NCBI
|
